Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals
There is converging evidence for impairments in decision-making in chronic substance users. In the light of findings that substance abuse is associated with disruptions of the functioning of the striato–thalamo–orbitofrontal circuits, it has been suggested that decision-making impairments are linked to frontal lobe dysfunction. We sought to investigate this possibility using functional neuroimaging.
Decision-making was investigated using the Cambridge Risk Task during H2 15O PET scans. A specific feature of the Risk Task is the decisional conflict between an unlikely high reward option and a likely low reward option. Four groups, each consisting of 15 participants, were compared: chronic amphetamine users, chronic opiate users, ex-drug users who had been long-term amphetamine/opiate users but are abstinent from all drugs of abuse for at least 1 year and healthy matched controls without a drug-taking history.
During decision-making, control participants showed relatively greater activation in the right dorsolateral prefrontal cortex, whereas participants engaged in current or previous drug use showed relatively greater activation in the left orbitofrontal cortex.
Our results indicate a disturbance in the mediation by the prefrontal cortex of a risky decision-making task associated with amphetamine and opiate abuse. Moreover, this disturbance was observed in a group of former drug users who had been abstinent for at least 1 year.
KeywordsAmphetamine Opiates Abstinence Substance abuse Decision making Risk taking Orbitofrontal Dorsolateral Prefrontal Neuroimaging
We would like to thank our volunteers without whom this study would not have been possible, particularly those who aided with recruitment, as well as the key workers Nick Schiller and Marion Martin and members of Narcotics Anonymous. We also thank Dr. Robert Rogers for providing the Risk Task and the staff of the Wolfson Brain Imaging Centre. This work was funded by a Wellcome Trust Programme grant to Profs. T.W. Robbins, B.J. Everitt, B.J. Sahakian and Dr. A.C. Roberts and carried out within the MRC Centre for Behavioural and Clinical Neuroscience. K.D. Ersche received a generous donation for research work on substance abuse from the Fund for Addenbrooke’s and P.C. Fletcher was supported by the Wellcome Trust.
- Alleyne BC, Stuart P, Copes R (1991) Alcohol and other drug-use in occupational fatalities. J Occup Environ Med 33:496–500Google Scholar
- American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders—4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
- Beck AT, Steer RA, Brown GK (1996) Manual for Beck Depression Inventory-II. Psychological Corporation, San Antonio, TXGoogle Scholar
- Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57:289–300Google Scholar
- British Medical Association (1995) Alcohol: guidelines on sensible drinking. BMA, LondonGoogle Scholar
- Damasio AR (1994) Descartes’ error: emotion, reason, and the human brain. Grosset/Pullman, New YorkGoogle Scholar
- EMCDDA (1999) Literature review of the relation between drug use, impaired driving and traffic accidents. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), LisbonGoogle Scholar
- Howell DC (1997) Statistical methods for psychology, 4th edn. Duxbury Press, LondonGoogle Scholar
- Nelson HE (1982) National adult reading test manual. NFER-Nelson, Windsor, UKGoogle Scholar
- Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JFW, Sahakian BJ, Robbins TW (1999a) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20:322–339CrossRefPubMedGoogle Scholar
- Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001) Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015–2021CrossRefPubMedGoogle Scholar